#United States #San Juan #Gynecologic Oncology #Women's Cancer #SGO

2026 SGO Annual Meeting: A Hub for Advancements in Women's Cancer

From April 10 to 13, 2026, the Society of Gynecologic Oncology (SGO) will hold its Annual Meeting in beautiful San Juan, Puerto Rico. This significant event promises to gather top-tier gynecologic oncologists, medical professionals, and researchers from around the globe to discuss the latest findings and treatment options in women's cancer. The focus will span several types of malignancies, including ovarian, cervical, uterine, vulvar, and vaginal cancers.

The SGO Annual Meeting is renowned for being the leading scientific forum dedicated solely to women's cancer. Each year, it attracts a multitude of participants, including gynecologic oncologists, medical oncologists, radiation oncologists, and nurses—all of whom play critical roles in the cancer care continuum. The meeting will not only share cutting-edge research but also foster collaborative discussions among healthcare providers from diverse backgrounds.

Innovative Research and Presentations

This year's program is particularly notable for featuring emerging clinical trial data and evolving therapeutic strategies. Participants can look forward to sessions that aim to influence practice and future guidelines in treating gynecologic cancers. Topics will include advancements in immunotherapy, novel biomarker-driven treatment strategies, and innovations in surgical techniques.

Dr. Karen H. Lu, SGO President and Physician in Chief at Moffitt Cancer Center, emphasizes the importance of collaboration in advancing gynecologic oncology. According to her, "The future of gynecologic oncology will be shaped not only by scientific discovery, but by how we come together to apply it."

The meeting will showcase oral and poster presentations from leading experts, highlighting a record number of abstract submissions this year, reflecting the rapid pace of discovery in the field. Notably, selected high-impact clinical findings will be unveiled during designated late-breaking sessions, maintaining an excitement throughout the event as attendees await groundbreaking revelations.

Engaging Keynote Speakers

In addition to scientific presentations, the Annual Meeting will feature an impressive lineup of keynote speakers, including Dr. Will Flanary, known as "Dr. Glaucomflecken," a physician and humorist whose unique perspectives on healthcare are not to be missed. Also scheduled to speak is Jess Wedel, a mountain guide and ovarian cancer survivor, whose inspiring journey reinforces the importance of resilience and advocacy in the realm of women's health.

These presentations will extend beyond research, addressing key facets of leadership and team development essential for delivering high-quality cancer care. With the growing complexity of treatments and patient needs, these discussions will be invaluable for professionals looking to enhance their skills in multidisciplinary cancer management.

Featured Exhibition

Another exciting component of the Annual Meeting will be an exhibition hall showcasing the latest advancements in medical devices, pharmaceuticals, and supportive services for gynecologic cancer care. Attendees will have a unique opportunity to explore emerging technologies designed to improve patient outcomes and share insights with companies dedicated to supporting oncology practices.

Empowering Patients and Advocates

Alongside the conference, the Foundation for Women's Cancer (FWC) will launch its inaugural Spanish-language Patient and Advocate Education Forum. This forum aims to bridge the gap in cancer education for Spanish-speaking patients, survivors, and advocates. Leading experts will offer insights into prevention, diagnosis, treatment, and supportive care in an inclusive environment designed to enhance community engagement.

By facilitating this forum alongside the Annual Meeting, both SGO and FWC are committed to expanding access to reliable cancer education beyond the professional scope, enriching knowledge and understanding within Hispanic communities.

Conclusion

As the countdown to the 2026 SGO Annual Meeting begins, the anticipation grows for what promises to be a transformative gathering for healthcare professionals dedicated to advancing women's cancer care. With a focus on research, education, and community engagement, this meeting will be a pivotal moment in the ongoing fight against gynecologic malignancies. Participants are encouraged to register early to secure their place at this vital event and contribute to shaping the future of gynecologic oncology. For more information, visit sgo.org.